FDA Approved: XARELTO — Original Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA documents the approval of the original application for Xarelto (rivaroxaban) from Janssen Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Nonvalvular Atrial Fibrillation
• Postoperative Prophylaxis of Venous Thromboembolism After Hip Replacement
• Postoperative Prophylaxis of Venous Thromboembolism After Knee Replacement
• Pulmonary Embolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

ORIG AP for XARELTO (RIVAROXABAN)